Diabetes Retinopathy

Diabetic retinopathy is characterized by changes in the retinal small blood vessels that can lead to macular edema, new vessel formation and vision loss. Hypertension has been identified as a major risk factor for diabetic retinopathy and clinical trials have shown that reduction of blood pressure using angiotensin converting enzyme (ACE) inhibitors reduces the progression of diabetic retinopathy. J Hypertens Suppl, 2006 Mar; 24(1):S73-80

The major components of the renin-angiotensin system have been identified in eye tissues. They examined the experimental and clinical evidence for the role of the renin-angiotensin system in the on diabetes-induced abnormalities in retinal vascular permeability and retinal new vessel formation.

We have had good success using the ARB class, especially Diovan, l-arginine 5 gm and with Byetta to get exceptional success at reversing all the retinal lesions that are not scars.